Studies also revealed that continuous IL-10 administration in models of experimental colitis (IL-10-deficient mice, T cell transfer-induced mice colitis models, and DSS- and TNBS-induced colitis mice) can improve intestinal symptoms. This evidence concerns the gene IL10 and colitis.